Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 71, Issue 2, 2009, Pages 214-222

  Khdair, Ayman ^a,b   Handa, Hitesh ^c   Mao, Guangzhao ^c   Panyam, Jayanth ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Wayne State University   (United States)

Author keywords

Cellular delivery; Cytotoxicity; Drug efflux; Nanoparticles; Nuclear delivery; Photodynamic therapy; Photosensitizer; Reactive oxygen species

Indexed keywords

ALGINIC ACID; DOXORUBICIN; METHYLENE BLUE; NANOPARTICLE; POLYVINYLCHLORIDE; REACTIVE OXYGEN METABOLITE;

AEROSOL; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; ENCAPSULATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSTIMULATION; QUANTITATIVE ANALYSIS;

ALGINATES; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; DIOCTYL SULFOSUCCINIC ACID; DOXORUBICIN; DRUG CARRIERS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; METHYLENE BLUE; NANOPARTICLES; P-GLYCOPROTEIN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES;

EID: 59649091887     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.08.017     Document Type: Article

References (43)

1. Shabbits J.A., Krishna R., and Mayer L.D. Molecular and pharmacological strategies to overcome multidrug resistance. Expert. Rev. Anticancer Ther. 1 (2001) 585-594
2. Leonard G.D., Fojo T., and Bates S.E. The role of ABC transporters in clinical practice. Oncologist 8 (2003) 411-424
3. Kaufmann A.M., and Krise J.P. Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications. J. Pharm. Sci. 96 (2007) 729-746
4. Alabaster O., Woods T., Ortiz-Sanchez V., and Jahangeer S. Influence of microenvironmental pH on adriamycin resistance. Cancer Res. 49 (1989) 5638-5643
5. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., and Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90 (1998) 889-905
6. Brown S.B., Brown E.A., and Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5 (2004) 497-508
7. *-) and singlet oxygen (1O2) by hypocrellin B in TX-100 micelles microsurroundings. Free Radic. Res. 37 (2003) 1107-1112
8. Diamond I., Granelli S.G., McDonagh A.F., Nielsen S., Wilson C.B., and Jaenicke R. Photodynamic therapy of malignant tumours. Lancet 2 (1972) 1175-1177
9. Trindade G.S., Farias S.L., Rumjanek V.M., and Capella M.A. Methylene blue reverts multidrug resistance: sensitivity of multidrug resistant cells to this dye and its photodynamic action. Cancer Lett. 151 (2000) 161-167
10. Lou P.J., Lai P.S., Shieh M.J., Macrobert A.J., Berg K., and Bown S.G. Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization. Int. J. Cancer 119 (2006) 2692-2698
11. Berg K., Dietze A., Kaalhus O., and Hogset A. Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin. Clin. Cancer Res. 11 (2005) 8476-8485
12. Zeisser-Laboue'be M., Vargas A., and Delie F. In: Kumar C.S. (Ed). Nanoparticles for Photodynamic Therapy of Cancer. Nanomaterials for Cancer Therapy vol. 1 (2006), Wiley-VCH 40-86 (Chapter 2)
13. Vargas A., Eid M., Fanchaouy M., Gurny R., and Delie F. In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties administration parameters and biological issues involved in PDT outcome. Eur. J. Pharm. Biopharm. 69 (2008) 43-53
14. Roy I., Ohulchanskyy T.Y., Pudavar H.E., Bergey E.J., Oseroff A.R., Morgan J., Dougherty T.J., and Prasad P.N. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J. Am. Chem. Soc. 125 (2003) 7860-7865
15. Barraud L., Merle P., Soma E., Lefrancois L., Guerret S., Chevallier M., Dubernet C., Couvreur P., Trepo C., and Vitvitski L. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J. Hepatol. 42 (2005) 736-743
16. Betancourt T., Brown B., and Brannon-Peppas L. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation characterization and in vitro evaluation. Nanomedicine 2 (2007) 219-232
17. Koziara J.M., Whisman T.R., Tseng M.T., and Mumper R.J. In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors. J. Control. Release 112 (2006) 312-319
18. Chavanpatil M.D., Khdair A., and Panyam J. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules. Pharm. Res. 24 (2007) 803-810
19. H.A.F.R.G. Kelly, E.R. Jolly, P.A. Tove, The Pharmacokinetics and Metabolism of Dioctyl Sodium Sulfo-Succinate in Several Animal Species and Man, Report Submitted to WHO, Lederle Laboratories, American Cyanamid, 1973.
20. Shiraishi S., Imai T., and Otagiri M. Controlled-release preparation of indomethacin using calcium alginate gel. Biol. Pharm. Bull. 16 (1993) 1164-1168
21. Tziampazis E., and Sambanis A. Tissue engineering of a bioartificial pancreas: modeling the cell environment and device function. Biotechnol. Prog. 11 (1995) 115-126
22. Chavanpatil M.D., Khdair A., Patil Y., Handa H., Mao G., and Panyam J. Polymer-surfactant nanoparticles for sustained release of water-soluble drugs. J. Pharm. Sci. 96 (2007) 3379-3389
23. Kruh G.D., and Goldstein L.J. Doxorubicin and multidrug resistance. Curr. Opin. Oncol. 5 (1993) 1029-1034
24. Ren Y., Wei D., and Zhan X. Inhibition of P-glycoprotein and increasing of drug-sensitivity of a human carcinoma cell line (KB-A-1) by an antisense oligodeoxynucleotide-doxorubicin conjugate in vitro. Biotechnol. Appl. Biochem. 41 (2005) 137-143
25. Crescenzi E., Varriale L., Iovino M., Chiaviello A., Veneziani B.M., and Palumbo G. Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. Mol. Cancer Ther. 3 (2004) 537-544
26. Zimmermann A., Walt H., Haller U., Baas P., and Klein S.D. Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient. Cancer Chemother. Pharmacol. 51 (2003) 147-154
27. Tang W., Xu H., Kopelman R., and Philbert M.A. Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms. Photochem. Photobiol. 81 (2005) 242-249
28. Liscovitch M., and Ravid D. A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells. Cancer Lett. 245 (2007) 350-352
29. Minotti G., Menna P., Salvatorelli E., Cairo G., and Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56 (2004) 185-229
30. Plaetzer K., Kiesslich T., Krammer B., and Hammerl P. Characterization of the cell death modes and the associated changes in cellular energy supply in response to AlPcS4-PDT. Photochem. Photobiol. Sci. 1 (2002) 172-177
31. Almeida R.D., Manadas B.J., Carvalho A.P., and Duarte C.B. Intracellular signaling mechanisms in photodynamic therapy. Biochim. Biophys. Acta 1704 (2004) 59-86
32. Siu W.Y., Yam C.H., and Poon R.Y. G1 versus G2 cell cycle arrest after adriamycin-induced damage in mouse Swiss3T3 cells. FEBS Lett. 461 (1999) 299-305
33. Au C.M., Luk S.K., Jackson C.J., Ng H.K., Yow C.M., and To S.S. Differential effects of, photofrin 5-aminolevulinic acid and calphostin C on glioma cells. J. Photochem. Photobiol. B 85 (2006) 92-101
34. Vakrat-Haglili Y., Weiner L., Brumfeld V., Brandis A., Salomon Y., McLlroy B., Wilson B.C., Pawlak A., Rozanowska M., Sarna T., and Scherz A. The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. J. Am. Chem. Soc. 127 (2005) 6487-6497
35. Bronshtein I., Smith K.M., and Ehrenberg B. The effect of pH on the topography of porphyrins in lipid membranes. Photochem. Photobiol. 81 (2005) 446-451
36. Bazargan L., Fouladdel S., Shafiee A., Amini M., Ghaffari S.M., and Azizi E. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro. Cell Biol. Toxicol. 24 (2008) 165-174
37. Harker W.G., Bauer D., Etiz B.B., Newman R.A., and Sikic B.I. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. Cancer Res. 46 (1986) 2369-2373
38. Chavanpatil M.D., Khdair A., Gerard B., Bachmeier C., Miller D.W., Shekhar M.P., and Panyam J. Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux. Mol. Pharm. 4 (2007) 730-738
39. Soma C.E., Dubernet C., Bentolila D., Benita S., and Couvreur P. Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. Biomaterials 21 (2000) 1-7
40. de Verdiere A.C., Dubernet C., Nemati F., Soma E., Appel M., Ferte J., Bernard S., Puisieux F., and Couvreur P. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. Br. J. Cancer 76 (1997) 198-205
41. Walker I., Gorman S.A., Cox R.D., Vernon D.I., Griffiths J., and Brown S.B. A comparative analysis of phenothiazinium salts for the photosensitisation of murine fibrosarcoma (RIF-1) cells in vitro. Photochem. Photobiol. Sci. 3 (2004) 653-659
42. Goren D., Horowitz A.T., Tzemach D., Tarshish M., Zalipsky S., and Gabizon A. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin. Cancer Res. 6 (2000) 1949-1957
43. A. Khdair, B. Gerard, H. Handa, G. Mao, M.P. Shekhar, J. Panyam, Surfactant-Polymer Nanoparticles Enhance the Effectiveness of Anticancer Photodynamic Therapy, Mol. Pharm., (2008), in press, doi: 10.1021/mp800026t (Epub ahead of print).